These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15225685)

  • 21. Benzothiophene and naphthalene derived constrained SERMs.
    Wallace OB; Bryant HU; Shetler PK; Adrian MD; Geiser AG
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5103-6. PubMed ID: 15380208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.
    Zhu M; Zhang C; Nwachukwu JC; Srinivasan S; Cavett V; Zheng Y; Carlson KE; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    Org Biomol Chem; 2012 Nov; 10(43):8692-700. PubMed ID: 23033157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based approach for the discovery of novel selective estrogen receptor modulators.
    Rosano C; Stec-Martyna E; Lappano R; Maggiolini M
    Curr Med Chem; 2011; 18(8):1188-94. PubMed ID: 21291367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein structure-based design, synthesis strategy and in vitro pharmacological characterization of estrogen receptor alpha and beta selective compounds.
    Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Elger W; Fritzemeier KH
    Ernst Schering Res Found Workshop; 2004; (46):47-62. PubMed ID: 15248504
    [No Abstract]   [Full Text] [Related]  

  • 28. A new series of estrogen receptor modulators: effect of alkyl substituents on receptor-binding affinity.
    Kamada A; Sasaki A; Kitazawa N; Okabe T; Nara K; Hamaoka S; Araki S; Hagiwara H
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):79-88. PubMed ID: 14709872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 31. Potent estrogen receptor ligands based on bisphenols with a globular hydrophobic core.
    Endo Y; Yoshimi T; Ohta K; Suzuki T; Ohta S
    J Med Chem; 2005 Jun; 48(12):3941-4. PubMed ID: 15943468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator.
    Zhang JX; Labaree DC; Mor G; Hochberg RB
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the diastereomerism of dihydrobenzoxathiin SERMs for ER alpha by molecular modeling.
    Zhuang S; Zhang J; Zhang F; Zhang Z; Wen Y; Liu W
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7298-305. PubMed ID: 22061644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and preclinical characterization of (+)-3-[4-(1- piperidinoethoxy)phenyl]spiro[indene- 1,1'-indane]-5,5'-diol hydrochloride: a promising nonsteroidal estrogen receptor agonist for hot flush.
    Watanabe N; Ikeno A; Minato H; Nakagawa H; Kohayakawa C; Tsuji J
    J Med Chem; 2003 Sep; 46(19):3961-4. PubMed ID: 12954049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
    Grese TA; Pennington LD; Sluka JP; Adrian MD; Cole HW; Fuson TR; Magee DE; Phillips DL; Rowley ER; Shetler PK; Short LL; Venugopalan M; Yang NN; Sato M; Glasebrook AL; Bryant HU
    J Med Chem; 1998 Apr; 41(8):1272-83. PubMed ID: 9548817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Photoswitchable Estrogen Receptor Ligands.
    Tsuchiya K; Umeno T; Tsuji G; Yokoo H; Tanaka M; Fukuhara K; Demizu Y; Misawa T
    Chem Pharm Bull (Tokyo); 2020; 68(4):398-402. PubMed ID: 32238658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-(4-alkylpiperazin-1-yl)phenyl group: a novel class of basic side chains for selective estrogen receptor modulators.
    Watanabe N; Nakagawa H; Ikeno A; Minato H; Kohayakawa C; Tsuji J
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4317-20. PubMed ID: 14643317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [2.2.1]-Bicyclic sultams as potent androgen receptor antagonists.
    Shan W; Balog A; Nation A; Zhu X; Chen J; Cvijic ME; Geng J; Rizzo CA; Spires T; Attar RM; Obermeier M; Traeger S; Dai J; Zhang Y; Galella M; Trainor G; Vite GD; Gavai AV
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5707-5711. PubMed ID: 27836399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.